230 related articles for article (PubMed ID: 32190695)
1. Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study.
Zhang H; Zuo JJ; Dong SS; Lan Y; Wu CW; Mao GY; Zheng C
J Diabetes Res; 2020; 2020():3049098. PubMed ID: 32190695
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
[TBL] [Abstract][Full Text] [Related]
3. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus.
Zuo J; Lan Y; Hu H; Hou X; Li J; Wang T; Zhang H; Zhang N; Guo C; Peng F; Zhao S; Wei Y; Jia C; Zheng C; Mao G
BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33593748
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
[TBL] [Abstract][Full Text] [Related]
7. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509122
[TBL] [Abstract][Full Text] [Related]
8. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
[TBL] [Abstract][Full Text] [Related]
9. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.
Jiang X; Liu X; Qu X; Zhu P; Wo F; Xu X; Jin J; He Q; Wu J
Theranostics; 2023; 13(10):3188-3203. PubMed ID: 37351171
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
12. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
13. Serum integrative omics reveals the landscape of human diabetic kidney disease.
Liu S; Gui Y; Wang MS; Zhang L; Xu T; Pan Y; Zhang K; Yu Y; Xiao L; Qiao Y; Bonin C; Hargis G; Huan T; Yu Y; Tao J; Zhang R; Kreutzer DL; Zhou Y; Tian XJ; Wang Y; Fu H; An X; Liu S; Zhou D
Mol Metab; 2021 Dec; 54():101367. PubMed ID: 34737094
[TBL] [Abstract][Full Text] [Related]
14. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus.
Abdelsattar S; Kasemy ZA; Elsayed M; Elrahem TA; Zewain SK
Br J Biomed Sci; 2021 Oct; 78(4):184-190. PubMed ID: 33656967
[No Abstract] [Full Text] [Related]
15. Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease.
Feng X; Huang J; Peng Y; Xu Y
BMC Endocr Disord; 2021 Jan; 21(1):1. PubMed ID: 33407357
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic biomarkers in diabetic kidney diseases--A systematic review.
Zhang Y; Zhang S; Wang G
J Diabetes Complications; 2015; 29(8):1345-51. PubMed ID: 26253264
[TBL] [Abstract][Full Text] [Related]
17. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
Pan Y; Yang H; Chen T; Jin J; Ruan L; Hu L; Chen L
Ren Fail; 2022 Dec; 44(1):1840-1849. PubMed ID: 36368309
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
[TBL] [Abstract][Full Text] [Related]
20. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
